Suggested

Trending

ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
00:03:24

ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
Free HD
209 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
00:02:59

CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
Free HD
235 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
00:08:45

CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
Free HD
135 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Should all HL patients be treated the same
00:03:44

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Should all HL patients be treated the same
Free HD
120 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Latest Videos

Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
0:07:00

Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
Free HD
138 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Caron Jacobson, MD on Interim Analysis of ZUMA-5 #ASCO2020 @DanaFarber
0:05:32

Caron Jacobson, MD on Interim Analysis of ZUMA-5 #ASCO2020 @DanaFarber
Free HD
7 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
John Kuruvilla, MD on A New Standard in Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
0:02:15

John Kuruvilla, MD on A New Standard in Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
Free HD
9 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
John Kuruvilla, MD on the Specific of the Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
0:02:51

John Kuruvilla, MD on the Specific of the Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
Free HD
33 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login